Development of sulfonamide AKT PH domain inhibitors
Keywords: طراحی دارو ; AKT; protein kinase B; β-ARK; β-adrenergic receptor kinase; CREB; cAMP response element-binding; DMEM; Dulbecco's modified Eagle medium; DPIEL; deoxyphosphatidylinositol ether lipid; ELISA; enzyme-linked immunosorbent assay; ESI; electrospray ionizati